Xenetic Biosciences, Inc. (XBIO) Trades at $2.03 After Triangle; TONG REN TANG TECHNOLOGIES ORDINARY SHAR (TGRNF) Shorts Raised By 38.94%

Xenetic Biosciences, Inc. (XBIO) formed triangle with $2.17 target or 7.00% above today’s $2.03 share price. Xenetic Biosciences, Inc. (XBIO) has $17.70 million valuation. The stock increased 0.50% or $0.01 during the last trading session, reaching $2.03. About 9,904 shares traded. Xenetic Biosciences, Inc. (OTCMKTS:XBIO) has declined 68.13% since March 23, 2017 and is downtrending. It has underperformed by 84.83% the S&P500.

TONG REN TANG TECHNOLOGIES ORDINARY SHAR (OTCMKTS:TGRNF) had an increase of 38.94% in short interest. TGRNF’s SI was 859,500 shares in March as released by FINRA. Its up 38.94% from 618,600 shares previously. With 100 avg volume, 8595 days are for TONG REN TANG TECHNOLOGIES ORDINARY SHAR (OTCMKTS:TGRNF)’s short sellers to cover TGRNF’s short positions. The SI to TONG REN TANG TECHNOLOGIES ORDINARY SHAR’s float is 0.14%. It closed at $1.48 lastly. It is down 0.00% since March 23, 2017 and is . It has underperformed by 16.70% the S&P500.

Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, makes and sells Chinese medicines primarily in Mainland China and Hong Kong. The company has market cap of $. It offers its products in the form of granules, water-honeyed pills, tablets, and soft capsules. It currently has negative earnings. The firm also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, foot care products, and healthcare products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services.